Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

Author:

Getahun Haileyesus,Matteelli Alberto,Abubakar Ibrahim,Aziz Mohamed Abdel,Baddeley Annabel,Barreira Draurio,Den Boon Saskia,Borroto Gutierrez Susana Marta,Bruchfeld Judith,Burhan Erlina,Cavalcante Solange,Cedillos Rolando,Chaisson Richard,Chee Cynthia Bin-Eng,Chesire Lucy,Corbett Elizabeth,Dara Masoud,Denholm Justin,de Vries Gerard,Falzon Dennis,Ford Nathan,Gale-Rowe Margaret,Gilpin Chris,Girardi Enrico,Go Un-Yeong,Govindasamy Darshini,D. Grant Alison,Grzemska Malgorzata,Harris Ross,Horsburgh Jr C. Robert,Ismayilov Asker,Jaramillo Ernesto,Kik Sandra,Kranzer Katharina,Lienhardt Christian,LoBue Philip,Lönnroth Knut,Marks Guy,Menzies Dick,Migliori Giovanni Battista,Mosca Davide,Mukadi Ya Diul,Mwinga Alwyn,Nelson Lisa,Nishikiori Nobuyuki,Oordt-Speets Anouk,Rangaka Molebogeng Xheedha,Reis Andreas,Rotz Lisa,Sandgren Andreas,Sañé Schepisi Monica,Schünemann Holger J.,Sharma Surender Kumar,Sotgiu Giovanni,Stagg Helen R.,Sterling Timothy R.,Tayeb Tamara,Uplekar Mukund,van der Werf Marieke J.,Vandevelde Wim,van Kessel Femke,van't Hoog Anna,Varma Jay K.,Vezhnina Natalia,Voniatis Constantia,Vonk Noordegraaf-Schouten Marije,Weil Diana,Weyer Karin,Wilkinson Robert John,Yoshiyama Takashi,Zellweger Jean Pierre,Raviglione Mario

Abstract

Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health approach to the management of LTBI in high risk individuals in countries with high or middle upper income and TB incidence of <100 per 100 000 per year. The guidelines strongly recommend systematic testing and treatment of LTBI in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor treatment, patients receiving dialysis, patients preparing for organ or haematological transplantation, and patients with silicosis. In prisoners, healthcare workers, immigrants from high TB burden countries, homeless persons and illicit drug users, systematic testing and treatment of LTBI is conditionally recommended, according to TB epidemiology and resource availability. Either commercial interferon-gamma release assays or Mantoux tuberculin skin testing could be used to test for LTBI. Chest radiography should be performed before LTBI treatment to rule out active TB disease. Recommended treatment regimens for LTBI include: 6 or 9 month isoniazid; 12 week rifapentine plus isoniazid; 3–4 month isoniazid plus rifampicin; or 3–4 month rifampicin alone.

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference71 articles.

Cited by 471 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3